Morbilidad y mortalidad en una serie de pacientes con neoplasias del peritoneo, tratados con citorreducción peritoneal más quimioterapia hipertérmica intraperitoneal en el Hospital Universitario de la Fundación Santa Fe de Bogotá (ONCOLGroup - estudio ATIA)

Glockzin, 2009, Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, World J Surg Oncol, 7, 5, 10.1186/1477-7819-7-5 Sadeghi, 2000, Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study, Cancer, 88, 358, 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O Yan, 2007, Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma, Ann Surg Oncol, 14, 41, 10.1245/s10434-006-9169-7 Arch-Ferrer, 2001, Tratamiento quirúrgico del cáncer colorrectal, Experiencia de 10 años en el INCMNSZ, Rev Gastroenterol Mex, 66, 187 Sugarbaker, 1999, Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy, Ann Surg Oncol, 6, 727, 10.1007/s10434-999-0727-7 Esquivel, 2008, Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination, J Surg Oncol, 98, 263, 10.1002/jso.21053 Verwaal, 2003, Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer, J Clin Oncol, 21, 3737, 10.1200/JCO.2003.04.187 Yan, 2007, Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases, Ann Surg Oncol, 14, 515, 10.1245/s10434-006-9187-5 Di Giorgio, 2008, Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer, Cancer, 113, 315, 10.1002/cncr.23553 Hirose, 1999, Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis, Oncology, 57, 106, 10.1159/000012016 Glehen, 2004, Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer, Arch Surg, 139, 20, 10.1001/archsurg.139.1.20 Cheong, 2007, Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer, Ann Surg Oncol, 14, 61, 10.1245/s10434-006-9205-7 Glehen, 2004, Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study, J Clin Oncol, 22, 3284, 10.1200/JCO.2004.10.012 Feldman, 2003, Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy, J Clin Oncol, 21, 4560, 10.1200/JCO.2003.04.150 Alexander, 2004, Impact of tumor resection (Rxn) and intraperitoneal (IP) chemotherapy (CHRx) on health related quality of life (HRQL) in patients (Pts) with peritoneal surface malignancies (PSM), Ann Surg Oncol, 11, S109, 10.1007/BF02524154 McQuellon, 2003, Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis, Ann Surg Oncol, 10, 155, 10.1245/ASO.2003.03.067 McQuellon, 2007, Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis, Ann Surg Oncol, 14, 1105, 10.1245/s10434-006-9304-5 McQuellon, 2008, Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin, Ann Surg Oncol, 15, 125, 10.1245/s10434-007-9678-z McQuellon, 2009, Assesing depressive symptoms with the Center of Epidemiologic Studies Depression-Scale prior cytoreductive surgery + intraperitoneal hyperthermic chemotherapy, Psycho-Oncology, 18, S42 Verwaal, 2008, 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer, Ann Surg Oncol, 15, 2426, 10.1245/s10434-008-9966-2 Yonemura, 2006, Quantitative prognostic indicators of peritoneal dissemination of gastric cancer, Eur J Surg Oncol, 32, 602, 10.1016/j.ejso.2006.03.003 Bryant, 2005, Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei, Br J Surg, 92, 153, 10.1002/bjs.4862 Consultado el 26 de enero de 2011. Disponible en www.nice.org.uk Yan, 2007, A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma, Ann Oncol, 18, 827, 10.1093/annonc/mdl428 Esquivel, 1998, Elective surgery in recurrent colon cancer with peritoneal seeding: when to and when not to proceed, Cancer Therapeutics, 1, 321 Sugarbaker, 2006, Technical, procedures Arias, 2009, Pseudomyxoma peritonei: first cases treated by radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, Rev Col Cirug, 24, 10 Lanuke, 2009, A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, Can J Surg, 52, 18 Sugarbaker, 2006, Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy, Ann Surg Oncol, 13, 635, 10.1245/ASO.2006.03.079 Smeenk, 2006, Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures, Eur J Surg Oncol, 32, 186, 10.1016/j.ejso.2005.08.009 Geerts, 2004, Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 338s, 10.1378/chest.126.3_suppl.338S Alcalay, 2006, Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival, J Clin Oncol, 24, 1112, 10.1200/JCO.2005.04.2150 Mandalá, 2006, The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma, Thromb Haemost, 95, 752, 10.1160/TH05-10-0657 Sardi, 2010, Prophylactic IVC filters in patients undergoing Cytoreductive and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Chua, 2010, Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment, Ann Surg, 251, 101, 10.1097/SLA.0b013e3181b5ae43 Saxena, 2010, A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis, World J Surg, 34, 70, 10.1007/s00268-009-0206-0 Saxena, 2010, Postoperative pancreatic fístula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: incidence, risk factors, management, and clinical sequelae, Ann Surg Oncol, 17, 1302, 10.1245/s10434-009-0898-2 Kusamura, 2007, Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity, Ann Surg Oncol, 14, 2550, 10.1245/s10434-007-9429-1 Galani, 2003, Pseudomyxoma peritonei: the ‘controversial’ disease, Int J Gynecol Cancer, 13, 413, 10.1046/j.1525-1438.2003.13318.x Moran, 2006, Establishment of a peritoneal malignancy treatment centre in the United Kingdom, Eur J Surg Oncol, 32, 614, 10.1016/j.ejso.2006.03.005 Mohamed, 2009, Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve, Cancer J, 15, 196, 10.1097/PPO.0b013e3181a58d56 Yan, 2007, A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei, Ann Surg Oncol, 14, 484, 10.1245/s10434-006-9182-x Gilly, 2006, Quantitative prognostic indices in peritoneal carcinomatosis, Eur J Surg Oncol, 32, 597, 10.1016/j.ejso.2006.03.002 Ferreira, 2005, Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy in the Treatment of Peritoneal Dissemination of Neoplasias: Preliminary Results with Closed Perfusio Technique, Appl Cancer Res, 25, 82 Gori, 2003, Quimioterapia intraperitoneal con hipertermia en el cáncer de ovario/Intraperitoneal Hyperthermic Chemotherapy in ovarian cancer treatment, Obstet Gynecol Latinoam, 61, 3 Chua, 2011, Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy, Am J Surg, 201, 149, 10.1016/j.amjsurg.2010.02.012 Sugarbaker, 2011, Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives), Am J Surg, 201, 157, 10.1016/j.amjsurg.2010.04.010